A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer
Emma J. West, Alain Sadoun, Kaidre Bendjama, Philippe Erbs, Cristina Smolenschi, Philippe A. Cassier, Thierry de Baere, Sophie Sainte-Croix, Maud Brandely, Alan A. Melcher, Fay Ismail, Karen J. Scott, Angela Bennett, Emma Banks, Ewa Gasior, Sarah Kent, Marta Kurzawa, Christopher Hammond, Jai V. Patel, Fiona J. Collinson, Chris Twelves, D. Alan Anthoney, Dan Swinson, Adel Samson
medRxiv 2024.07.30.24311046; doi: https://doi.org/10.1101/2024.07.30.24311046